title: The use of high-sensitivity assays for C-reactive protein in clinical practice.
abstract: High-sensitivity assays that accurately measure levels of the inflammatory biomarker C-reactive protein have been proposed for use in assessments of risk for cardiovascular disease (CVD). A growing body of evidence supports recommendations for these tests in selected asymptomatic individuals deemed to be at intermediate risk of CVD according to traditional risk-factor assessments and who do not already warrant chronic treatment with aspirin and statin therapy. Data suggests that these high-sensitivity assays should be used in combination with measurements of LDL-cholesterol levels to assist risk stratification of selected patients for prevention of CVD.
authors: Johns Hopkins Ciccarone Preventive Cardiology Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. kmusunu1@jhmi.edu
authors: Kiran
authors: K
authors: Musunuru
authors: Brian G
authors: BG
authors: Kral
authors: Roger S
authors: RS
authors: Blumenthal
authors: Valentin
authors: V
authors: Fuster
authors: Catherine Y
authors: CY
authors: Campbell
authors: Ty J
authors: TJ
authors: Gluckman
authors: Richard A
authors: RA
authors: Lange
authors: Eric J
authors: EJ
authors: Topol
authors: James T
authors: JT
authors: Willerson
authors: Milind Y
authors: MY
authors: Desai
authors: Michael H
authors: MH
authors: Davidson
authors: Samia
authors: S
authors: Mora
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D003362:Cost-Benefit Analysis; D048909:Diabetes Complications / Q000097:blood / Q000209:etiology; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000097:blood / Q000150:complications; D018836:Inflammation Mediators / Q000097:blood*; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications; D008875:Middle Aged; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D055502:Secondary Prevention; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018836:Inflammation Mediators; D002097:C-Reactive Protein